New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.
Changes in governance with the appointment of a new Chairman of the Board of Directors and a new Director Regrouping of all French Advicenne's teams in the new Paris headquarters to optimize
- The financing will support development of a commercial instrument system based on the company's proprietary and disruptive MAGNA technology. - MAGNA is set to unlock the field of dynamic